BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Ligand Provides Highlights from Today’s Analyst Day Event - Nov. 15, 2017

  The webcast is available at www.ligand.com.

  November 14, 2017

   · 

  16 min read
• Business

  Audentes Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Audentes Therapeutics today reported its financial results for the quarter ended September 30, 2017, and provided an update on the company’s recent achievements and anticipated upcoming milestones.

  November 14, 2017

   · 

  10 min read
• Genetown

  Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2043

  Hologic announced today that holders of the 2.00% Convertible Senior Notes due 2043 issued February 21, 2013 have the right to surrender their notes for repurchase by the Company.

  November 14, 2017

   · 

  4 min read
• Valeant Announces Pricing of Private Offering of Add-on Secured Notes

  Valeant announced today that it has priced its previously announced offering of $750,000,000 aggregate principal amount of its 5.500% senior secured notes due 2025.

  November 14, 2017

   · 

  4 min read
• BioCapital

  QIAGEN’s GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology

  The studies are being presented this week at the AMP 2017 Annual Meeting in Salt Lake City, Utah, where QIAGEN also will demonstrate the GeneReader and other Sample to Insight solutions.

  November 14, 2017

   · 

  1 min read
• Drug Development

  Acceleron Announces Preclinical Results in Pulmonary Arterial Hypertension at the American Heart Association 2017 Scientific Sessions

  The company expects to initiate a Phase 2 trial in 1H 2018.

  November 14, 2017

   · 

  5 min read
• Business

  Simulations Plus Reports FY2017 and Fourth Quarter FY2017 Financial Results

  Earnings per share of $0.33, up 14.9% over prior year.

  November 14, 2017

   · 

  9 min read
• Business

  Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016

  Net revenue for the nine months ended September 30, 2017 was $6.4 million compared to $3.1 million for the same period in 2016.

  November 14, 2017

   · 

  11 min read
• Business

  NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results

  Sales of $4.1 million increased 19% year-over-year.

  November 14, 2017

   · 

  12 min read
• Drug Development

  Recruitment Completed in Trial to Evaluate The Optimal Dosing Frequency for Zealand’s Long-Acting GLP-2 Analog Glepaglutide

  The primary objective of the trial is to characterize the pharmacokinetic profile of glepaglutide and its primary active metabolites following once-daily and once-weekly subcutaneous (SC) injections and after a single intravenous (IV) infusion in healthy subjects.

  November 14, 2017

   · 

  3 min read